Skip to main content
. 2024 Mar 25;7(4):2036–2053. doi: 10.1021/acsabm.3c01205

Figure 8.

Figure 8

Schematic representation of the combined use of PTX/DCK and QRN in oral treatment had inhibitory effects on cell migration and proliferation in human lung carcinoma (A549). Reproduced with permission from ref (115). Copyright 2018 MDPI.